Ensign Peak Advisors Inc Cuts Stock Position in Colgate-Palmolive Company $CL

Ensign Peak Advisors Inc cut its position in Colgate-Palmolive Company (NYSE:CL) by 2.4% in the second quarter, HoldingsChannel.com reports. The firm owned 639,935 shares of the company’s stock after selling 15,578 shares during the period. Ensign Peak Advisors Inc’s holdings in Colgate-Palmolive were worth $58,170,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. Empirical Finance LLC grew its position in shares of Colgate-Palmolive by 0.6% in the 2nd quarter. Empirical Finance LLC now owns 29,129 shares of the company’s stock worth $2,648,000 after buying an additional 182 shares during the last quarter. Wealthspire Advisors LLC grew its holdings in Colgate-Palmolive by 1.2% in the second quarter. Wealthspire Advisors LLC now owns 25,538 shares of the company’s stock worth $2,321,000 after purchasing an additional 300 shares during the last quarter. Cordatus Wealth Management LLC increased its position in shares of Colgate-Palmolive by 0.6% during the second quarter. Cordatus Wealth Management LLC now owns 23,036 shares of the company’s stock worth $2,094,000 after purchasing an additional 134 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Colgate-Palmolive by 1.2% during the 2nd quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock valued at $7,522,129,000 after purchasing an additional 993,432 shares during the last quarter. Finally, Invenio Wealth Partners LLC boosted its position in shares of Colgate-Palmolive by 29.4% in the 2nd quarter. Invenio Wealth Partners LLC now owns 3,297 shares of the company’s stock worth $300,000 after purchasing an additional 749 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $78.93 on Friday. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $100.18. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The company has a market cap of $63.62 billion, a PE ratio of 22.17, a price-to-earnings-growth ratio of 4.44 and a beta of 0.35. The company’s 50 day moving average is $78.78 and its 200 day moving average is $84.91.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, October 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. During the same period in the prior year, the firm earned $0.91 EPS. The business’s revenue for the quarter was up 1.9% on a year-over-year basis. On average, sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 14th. Shareholders of record on Friday, October 17th were paid a dividend of $0.52 per share. The ex-dividend date was Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.26%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Bank of America decreased their price target on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, October 8th. Raymond James Financial lowered their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research note on Monday, October 20th. Deutsche Bank Aktiengesellschaft set a $86.00 price target on shares of Colgate-Palmolive in a research note on Friday, October 10th. Finally, UBS Group lowered their price objective on shares of Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating for the company in a research note on Monday, November 3rd. Nine equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $89.87.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.